Skip to main
OMDA

OMDA Stock Forecast & Price Target

OMDA Analyst Ratings

Based on 12 analyst ratings
Buy
Strong Buy 33%
Buy 50%
Hold 17%
Sell 0%
Strong Sell 0%

Bulls say

Omada Health is a leader in the digital healthcare industry, with a proven track record of delivering measurable health outcomes and value to employers, health plans, and pharmacy benefit managers. With strong partnerships in the healthcare industry and a focus on chronic care, the company has experienced impressive growth in membership and revenue. Additionally, their innovative AI-driven tools and personalized programs have resulted in high engagement rates, leading to cost savings for their clients. As they continue to expand into new markets, such as Medicare, Omada Health's positive outlook remains strong as they strive to improve health outcomes and reduce healthcare costs.

Bears say

Omada Health is perceived as a risky investment due to its limited pricing power and customer concentration, with Cigna affiliates making up 66% of total revenue. While the company's platform and specialized care tracks show potential for growth and cost-savings for customers, a failure to deliver meaningful outcomes could put pressure on revenue growth. Additionally, operational issues and competition from other virtual healthcare companies could impact future business unfavorably. Furthermore, technology breaches pose a significant risk to the business and its confidential information. With a limited pricing power and concentration of key partnerships, there is a potential for OMDA's operations and prospects to suffer in the long term.

OMDA has been analyzed by 12 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 50% recommend Buy, 17% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omada Health Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omada Health Inc (OMDA) Forecast

Analysts have given OMDA a Buy based on their latest research and market trends.

According to 12 analysts, OMDA has a Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $25.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $25.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omada Health Inc (OMDA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.